Corner Bakery Cafe Celebrates 34 Sweet Years with Smiley Mugs, Free Coffee, and Funfetti Treats
To kick off the festivities on the big day, the first 34 guests in line at all Corner Bakery locations will receive the brand's Limited Edition iconic Smiley Mug, a nostalgic favorite making a special return for this limited-time birthday celebration. As an extra treat, these lucky guests will also receive an offer for FREE coffee for a year—no purchase necessary.
"Turning 34 is a milestone worth celebrating, and what better way to do that than by giving back to the guests who have supported us," said Chris Dharod, CEO of Corner Bakery. "We're thrilled to bring back the Smiley Mug, a symbol of warmth and hospitality that has been a part of Corner Bakery's history for years. This is just the beginning of an annual tradition that ensures we never let another year go by without celebrating what makes Corner Bakery so special -- our guests."
The celebration doesn't stop with the Smiley Mug. Corner Bakery loyalty members can enjoy FREE coffee all day long with any purchase, making the day the perfect opportunity to indulge in a favorite brew. And because no birthday is complete without cake, every guest who walks through the doors will be treated to a FREE Funfetti Bundt Bite, a delightful, bite-sized nod to the joy of birthdays.
All day, guests are invited to join in the celebration by snapping a photo with their Smiley Mug or Funfetti treat and tagging Corner Bakery on social media. Whether stopping by for a morning coffee or an afternoon pick-me-up, it's the perfect chance to celebrate the moment, share in the fun, and make lasting memories.
Founded on a philosophy of creating a warm and comfortable place for people to relax with friends, family and neighbors, the restaurants feature artisan-inspired, seasonal hand-crafted menu options made with fresh ingredients every day, while delivering a premier bakery experience in the heart of neighborhoods across the nation.
Mark your calendars, set your reminders, and join us on April 10 for an unforgettable day of celebration and smiles! Be the first to be in line at the location near you -- the Smiley Mugs are back, the birthday candles are lit, and Corner Bakery is ready to celebrate 34 delicious years—one smile at a time. #sharethesmiles
For more information, visit cornerbakerycafesmileymug.com or follow Corner Bakery CafeⓇ on Facebook, Instagram, LinkedIn or TikTok.
*Pricing and hours vary by location.
ABOUT CORNER BAKERY CAFE
Corner Bakery Cafe is a fast-casual restaurant serving kitchen-crafted breakfast, lunch, dinner and catering to guests in 18 states and Washington, D.C. In 1991, inspired by great fresh ingredients, the small neighborhood bakery on a corner in downtown Chicago began creating artisan breads and freshly baked sweets. For the last 33 years, Corner Bakery Cafes have been a neighborhood favorite. Guest favorites include the crave-worthy Anaheim Scrambler for breakfast, the grilled-to-perfection Chicken Pomodori Panini for lunch, the kitchen-crafted Pesto Cavatappi pasta for dinner and a slice of rich, flavorful Cinnamon Creme Cake for a sweet treat. The catering menu includes freshly scrambled eggs and Berry & Almond Overnight Oats, baskets of assorted specialty sandwiches, signature pastas and hot and delicious soups. Corner Bakery Cafe is owned by an affiliate of SSCP, a Dallas-based enterprise and an award-winning leader in the restaurant industry. To learn more, visit cornerbakerycafe.com or follow Corner Bakery CafeⓇ on Facebook, Instagram, LinkedIn or TikTok.
View original content to download multimedia:https://www.prnewswire.com/news-releases/corner-bakery-cafe-celebrates-34-sweet-years-with-smiley-mugs-free-coffee-and-funfetti-treats-302420224.html
SOURCE Corner Bakery Cafe
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Roundhill Investments Surpasses $6 Billion AUM Milestone
Roundhill's ETF line-up features 9 ETFs with over $100 million in assets under management NEW YORK, Aug. 13, 2025 /PRNewswire/ -- Roundhill Investments, an ETF sponsor focused on innovative financial products, is proud to announce that the firm has officially surpassed $6 billion in assets under management (AUM). "Meeting this milestone is a testament to our mission of building differentiated ETFs that align with how investors want to allocate today to meet specific objectives and outcomes," said Dave Mazza, CEO of Roundhill Investments. "Crossing the $6 billion mark demonstrates that our approach of putting innovation first continues to resonate." Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Thor Metals Group: Best Overall Gold IRA Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Since its founding in 2018, Roundhill has emerged as a go-to provider for self-directed investors, particularly among Millennial and Gen Z audiences. The firm now offers a diverse line-up of more than 30 ETFs, 9 of which are over $100 million in assets. 1 Source: Bloomberg, as of 8/12/2025. About Roundhill InvestmentsFounded in 2018, Roundhill Investments is an SEC-registered investment advisor focused on innovative exchange-traded funds. Roundhill's suite of ETFs aims to offer distinct and differentiated exposures across thematic equity, options income, and trading vehicles. Roundhill offers a depth of ETF knowledge and experience, as the team has collectively launched more than 100+ ETFs including several first-to-market products. For more information, please visit Carefully consider the investment objectives, risks, charges and expenses of Roundhill ETFs before investing. This and other information about each fund is contained in the Prospectus and Summary Prospectus. Please read the prospectus and summary prospectus carefully before investing as it explains the risks associated with investing in the ETFs. Each Fund prospectus can be found on the individual Fund page under SEC registration does not imply a certain level of skill or training These include risks related to investments in small and mid-capitalization companies, which may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. Funds investments may be non-diversified, meaning its assets may be concentrated in fewer individual holdings than a diversified fund and, therefore, more exposed to individual stock volatility than diversified funds. Investments in foreign securities involves social and political instability, market illiquidity, exchange-rate fluctuation, high volatility and limited regulation risks. Emerging markets involve different and greater risks, as they are smaller, less liquid and more volatile than more develop countries. Depositary Receipts involve risks similar to those associated with investments in foreign securities, but may not provide a return that corresponds precisely with that of the underlying shares. All investing involves risk, including possible loss of principal. Please see the prospectus for specific risks related to each fund. Roundhill's funds are distributed by Foreside Fund Services, LLC. View original content to download multimedia: SOURCE Roundhill Investments Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
IFF Launches POWERFRESH ® ACE 2000, a Bread Fresh-Keeping Solution That ‘Aces' the Shelf-Life Test
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announces the launch of POWERFRESH® ACE 2000 to the U.S. market. This next-generation fresh-keeping enzyme solution is designed to help industrial bakeries deliver bread with improved softness, resilience and cohesiveness throughout shelf life — meeting specific consumer demands while improving operational efficiency. 'Developed by IFF's biosciences experts, this advancement underscores our commitment to helping bakeries deliver exceptional value and maintain a competitive edge in the industry,' said Clementina Dellomonaco, senior vice president of food biosciences at IFF. 'Whenever we enhance the consumer experience, we help our customers build stronger brand equity, drive repeat purchases and unlock long-term growth.' As ingredient prices rise and consumer expectations for long-lasting freshness continue to grow, U.S. bakeries face unprecedented pressure to maintain product quality without increasing operational strain. A recent survey shows that 60% of U.S. consumers would buy bread marketed as 'fresher for longer,' and more than half expect at least four days of freshness at purchase. 1 POWERFRESH® ACE 2000 addresses these priorities by improving softness and resilience for up to 34 days, while reducing waste and inventory complexity. In IFF-led trials, POWERFRESH® ACE 2000 demonstrated a strong performance across both white and whole-wheat bread applications. This enzyme consistently delivered superior resilience while maintaining structure and visual appeal, even at lower dosage levels compared to market alternatives, resulting in stable loaves with excellent texture and mouthfeel. Crucially, it preserved the soft, yet easy-to-butter texture that consumers prefer, even several days after purchase. 'As a staple food, bread is a regular fixture in consumers' baskets — so expectations for quality are high and constant,' said Emily Wagener, industry leader for food and beverage enzymes for North America at IFF. 'At the same time, bakeries face challenges that require smarter solutions. POWERFRESH® ACE 2000 is bakers' ally to deliver high-quality products with the delicious texture and freshness consumers expect, every time.' As the latest addition to IFF's established POWERFRESH® portfolio, this new solution offers a smarter path to consistent bread quality and efficiency — whether used in new formulations or to optimize existing ones. Improved product resilience enables industrial bakeries to extend distribution and better manage shelf-life targets. These operational gains also align with sustainability goals by reducing waste, minimizing returns and optimizing resources across the supply chain. Learn more about POWERFRESH® ACE 2000 and IFF's innovative bakery enzyme portfolio here. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products — advancing wellness, delighting the senses and enhancing the human experience. Learn more at LinkedIn, Instagram and Facebook. ©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Business Wire
an hour ago
- Business Wire
Glaukos Announces Participation in Wells Fargo Healthcare Conference
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 10:15 a.m. ET in Boston, MA. A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at About Glaukos Glaukos ( is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012. In 2024, Glaukos commenced commercial launch activities for iDose ® TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical designed to deliver 24/7 glaucoma drug therapy inside the eye for extended periods of time. Glaukos also markets the only FDA-approved corneal cross-linking therapy utilizing a proprietary bio-activated pharmaceutical for the treatment of keratoconus, a rarely diagnosed corneal disorder. Glaukos continues to successfully develop and advance a robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.
